Drug Profile
Research programme: oncolytic virus vaccines - Ignite Immunotherapy/Pfizer
Alternative Names: Intravenous oncolytic cancer vaccines - Ignite Immunotherapy/PfizerLatest Information Update: 28 Jan 2021
Price :
$50
*
At a glance
- Originator Ignite Immunotherapy
- Developer Ignite Immunotherapy; Pfizer
- Class Cancer vaccines; Immunotherapies; Oncolytic viruses
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer